Open AccessPractical consensus recommendation on when to do BRCA testing
Author(s) -
Purvish M. Parikh,
Jyoti Wadhwa,
S. Minhas,
Amit Gupta,
Sangeeta Mittal,
Subhash Ranjan,
Prashant G. Mehta,
Randeep Singh,
Sant Parkash Kataria,
Sarwat Salim,
Mushtaq Ahmed,
Sandeep Aggarwal
Publication year - 2018
Publication title -
south asian journal of cancer
Language(s) - English
Resource type - Journals
eISSN - 2278-4306
pISSN - 2278-330X
DOI - 10.4103/sajc.sajc_112_18
Subject(s) - medicine , brca mutation , genetic testing , breast cancer , mutation , cancer , oncology , family medicine , gynecology , genetics , gene , biology
BRCA-mutation associated breast cancer and to future cancer risks and sensitivity to systemic therapies. Now that rapid genetic testing for BRCA1 and BRCA2 mutations is available, BRCA mutation status can be considered when making treatment and prevention decisions for BRCA testing, BRCA mutation carriers with breast cancer. Expert group used data from published literature, practical experience, and opinion of a large group of academic oncologists, to arrive at practical consensus recommendations for use by the community oncologists.